Comparables Rejected in Transfer Pricing Case, TNMM Applied with Adjustments

The Tribunal concluded that Modicare Ltd. could not be considered a comparable company under the Resale Price Method due to lack of necessary data and significant differences. Consequently, the Tribunal directed the Transfer Pricing Officer to apply the Transactional Net Margin Method on the comparables selected by the assessee with suitable working capital adjustments. The appeals of the assessee were allowed, and the findings were applied mutatis mutandis for all the appeals.

---

---

Issues Involved:
1. Transfer Pricing Adjustment
2. Inclusion or Exclusion of Comparable Company (Modicare Ltd.)
3. Adoption of Resale Price Method (RPM) vs. Transactional Net Margin Method (TNMM)
4. Functional and Product Differences
5. Availability of Segmental Data
6. Comparability Adjustments

Detailed Analysis:

1. Transfer Pricing Adjustment:
The appeals were filed by the assessee against the orders for the Assessment Years 2009-10 to 2012-13, challenging the transfer pricing adjustments in the distribution and sales of cosmetic products. The adjustments were substantial, ranging from Rs. 14.29 crores to Rs. 48.90 crores across the years.

2. Inclusion or Exclusion of Comparable Company (Modicare Ltd.):
The primary issue was whether Modicare Ltd. should be included as a comparable company for the assessee, Oriflame India Pvt. Ltd. The Tribunal initially included Modicare Ltd. but was directed by the High Court to reconsider this decision due to significant differences between the two companies. The High Court observed that the Tribunal's findings were inconsistent and remanded the issue back to the Tribunal for a detailed examination.

3. Adoption of Resale Price Method (RPM) vs. Transactional Net Margin Method (TNMM):
The assessee adopted RPM to justify its arm’s length margin, selecting five comparable companies. However, the TPO rejected these comparables and included Modicare Ltd. as the sole comparable. The High Court directed the Tribunal to consider the applicability of TNMM as the most appropriate method if RPM could not be reliably applied.

4. Functional and Product Differences:
The assessee argued that Modicare Ltd. had a diversified product portfolio and different business models, making it incomparable. Modicare Ltd. dealt in various products like personal care, agriculture, tea, jewelry, healthcare, and cosmetics, unlike the assessee, which dealt only in cosmetics. The Tribunal noted these differences and highlighted the significant variance in gross and net margins, indicating heavy operating expenses and functional differences.

5. Availability of Segmental Data:
The High Court directed the Tribunal to examine the availability of data for various product segments of Modicare Ltd. The TPO's remand report confirmed that segmental data for Modicare Ltd. was not available, making it difficult to carry out accurate comparability adjustments.

6. Comparability Adjustments:
The Tribunal observed that due to the lack of segmental data and significant differences in product and functional profiles, accurate comparability adjustments were not feasible. The Tribunal highlighted that Modicare Ltd. had different accounting treatments for incentives/discounts and incurred substantial AMP expenses, which were not comparable to the assessee.

Conclusion:
The Tribunal concluded that Modicare Ltd. could not be considered a comparable company under RPM due to the lack of necessary data and significant differences. Consequently, the Tribunal directed the TPO to apply TNMM on the comparables selected by the assessee with suitable working capital adjustments. The appeals of the assessee were allowed, and the findings were applied mutatis mutandis for all the appeals.

---